Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · IEX Real-Time Price · USD
21.39
+0.25 (1.18%)
At close: May 24, 2024, 4:00 PM
21.02
-0.37 (-1.73%)
After-hours: May 24, 2024, 5:47 PM EDT

Fulgent Genetics Market Cap

Fulgent Genetics has a market cap or net worth of $640.08 million as of May 24, 2024. Its market cap has decreased by -39.62% in one year.

Market Cap
640.08M
Enterprise Value
334.80M
1-Year Change
-39.62%
Ranking
Category
Stock Price
$21.39

Market Cap Chart

Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $640.08M, an increase of 309.00%. That is a compound annual growth rate of 20.21%.

History

DateMarket Cap% Change
May 23, 2024632.60M-0.99%
May 22, 2024638.90M-0.33%
May 21, 2024641.00M-1.48%
May 20, 2024650.60M-1.66%
May 17, 2024661.60M-1.74%
May 16, 2024673.30M-0.31%
May 15, 2024675.40M1.12%
May 14, 2024667.90M0.59%
May 13, 2024664.00M2.01%
May 10, 2024650.90M-0.18%
May 9, 2024652.10M2.45%
May 8, 2024636.50M-0.24%
May 7, 2024638.00M-0.79%
May 6, 2024643.10M-0.05%
May 3, 2024643.40M1.71%
May 2, 2024632.60M2.61%
May 1, 2024616.50M1.72%
Apr 30, 2024606.10M-1.13%
Apr 29, 2024613.00M2.39%
Apr 26, 2024598.70M0.35%
Apr 25, 2024596.60M-3.42%
Apr 24, 2024617.70M0.47%
Apr 23, 2024614.80M0.39%
Apr 22, 2024612.40M0.99%
Apr 19, 2024606.40M1.24%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Dianthus Therapeutics 638.94M
Pediatrix Medical Group 638.68M
Paragon 28 636.24M
Quanterix 633.75M
iTeos Therapeutics 633.60M
ArriVent BioPharma 632.36M
Harrow Health 619.18M
Arbutus Biopharma 618.99M
Market Cap Rankings